EGFR L861Q + EGFR G719X
|
NSCLC
|
EGFR L861Q + EGFR G719X
|
NSCLC
|
afatinib Sensitive: C3 – Early Trials
|
afatinib Sensitive: C3 – Early Trials
|
EGFR L861Q + EGFR G719X
|
LUAD
|
EGFR L861Q + EGFR G719X
|
LUAD
|
afatinib Sensitive: C4 – Case Studies
|
afatinib Sensitive: C4 – Case Studies
|